Diebold Nixdorf, Incorporated (NYSE: DBD) Investor Securities Class Action Lawsuit 07/02/2019

If you purchased a significant amount of shares of Diebold Nixdorf, Incorporated (NYSE: DBD) between May 4, 2017 and July 4, 2017, and / or if you purchased any NYSE: DBD shares prior to May 2017 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: September 3, 2019. NYSE: DBD investors should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Diebold
Case Name: 
Diebold Sharerholder Class Action Lawsuit 07/02/2019
Case Status: 
Lawsuit Filed
Affected Securities
NYSE: DBD
Lawsuit Overview
Type of Lawsuit: 
Shareholder Class Action
Date Filed: 
07/02/2019
Class Period Begin: 
05/04/2017
Class Period End: 
07/04/2019
Court of Filing: 
U.S. District Court for the Southern District of New York
Deadline To File for Lead: 
09/03/2019
Summary: 

An investor in shares of Diebold Nixdorf, Incorporated (NYSE: DBD) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Diebold Nixdorf, Incorporated in connection with certain allegedly false and misleading statements made between May 4, 2017 and July 4, 2017.

On July 5, 2017, Diebold Nixdorf, Incorporated issued a announcement titled “Diebold Nixdorf Adjusts 2017 Financial Outlook” (the “July 2017 Press Release”). The announcement disclosed that Diebold Nixdorf, Incorporated expected a wider net loss than indicated in its prior guidance for fiscal 2017, from a range of $50 to $75 million to a range of $110 to $125 million net loss.
Diebold Nixdorf, Incorporated attributed the lowered expectations to a delay in systems rollouts as well as a longer customer decision-making process and order-to-revenue conversion cycle.

Shares of Diebold Nixdorf, Incorporated (NYSE: DBD) declined from $31.85 per share in February 2017 to as low as $16.25 per share in late 2017.

On July 2, 2019, Shares of Diebold Nixdorf, Incorporated (NYSE: DBD) closed at $9.31 per share.

According to the complaint the plaintiff alleges on behalf of purchasers of Diebold Nixdorf, Incorporated (NYSE: DBD) common shares between May 4, 2017 and July 4, 2017, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 4, 2017 and July 4, 2017, the Defendants made false and/or misleading statements and/or failed to disclose that the Company was experiencing delays in systems rollouts as well as a longer customer decision-making process and order-to-revenue conversion cycle, that the foregoing issues were negatively impacting the Company’s services business and operations, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.